Empowering a Genomics Lab for Growth
Problem
A pioneering genomics lab sought funding to scale its operations and
enhance its financial planning. The goal was to attract investors while
equipping internal teams with tools to drive strategic decision-making and
efficiency.
Beyond funding, they sought to develop a business model for offering
data products and services, enabling collaborations with pharmaceutical
and research companies to unlock new revenue streams.
Our Approach
We partnered with the lab to create a comprehensive financial model that projected future performance and profitability. A compelling pitch deck was crafted to showcase the lab’s value proposition and growth potential to investors.
To support the sales team, we developed a tailored sales module, breaking down unit economics for better understanding and performance tracking. Additionally, we conducted in-depth financial planning and analysis (FP&A) to help the strategy team analyze financials, set budgets, and align plans with growth objectives.
To help the lab recognize the untapped potential of data monetization, we conducted a thorough competitor analysis and reviewed precedent transactions in the genomics and biotech sectors. This helped pinpoint market trends and viable pricing strategies for their data offerings.
Outcome
With these strategic tools, the lab secured the necessary funding to scale its operations. Insights from competitor analysis and market precedents guided the lab in monetizing its data assets effectively, while the new business model opened doors for collaborations, enhancing market positioning.
Internally, the FP&A framework and sales module streamlined planning and empowered teams to pursue sustainable, data-driven growth.